Portland, Oregon
Cancer surgery and procedure trials in Portland, OR
63 cancer surgery and procedure studies are recruiting participants at sites in Portland as of November 18, 2026, according to ClinicalTrials.gov. Cancer Surgery Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Portland at a glance
- 63 studies are recruiting at a site in Portland.
- By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (4), Phase 2 (23), Phase 2/3 (1), Phase 3 (24), Phase 4 (2), No phase (2), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (47), government (15), industry (1).
- By research area: Lymphoma (23), Lung Cancer (13), Breast Cancer (9), Prostate Cancer (9), Pancreatic Cancer (6), Melanoma (3).
- Most recent update to one of these records: November 18, 2026.
Breast cancer studies recruiting in Portland
Basic details from each study's public record (the 30 most recently updated of 63). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05564377 · updated
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Legacy Good Samaritan Hospital and Medical Center · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT06058377 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05334069 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Lung cancer studies recruiting in Portland
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT06498635 · updated
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Kaiser Permanente Northwest · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT04267848 · updated
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT04181060 · updated
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT07293247 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Prostate cancer studies recruiting in Portland
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT03866382 · updated
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT04423211 · updated
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT06632977 · updated
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT07200830 · updated
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Phase 3
- Ages 18 and older
- Male participants
- Sponsor
- NRG Oncology
- Study sites
- Kaiser Permanente Northwest · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05946213 · updated
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
- Phase 4
- Ages 18 and older
- Male participants
- Sponsor
- OHSU Knight Cancer Institute
- Study site
- OHSU Knight Cancer Institute
- Registry record
- NCT05919329 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Melanoma studies recruiting in Portland
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05136196 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Portland, OR on ClinicalTrials.gov.
Lymphoma studies recruiting in Portland
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT03739814 · updated
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Kaiser Permanente Northwest · Oregon Health and Science University · Providence Portland Medical Center
- Registry record
- NCT06337318 · updated
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Legacy Emanuel Children's Hospital · Oregon Health and Science University
- Registry record
- NCT04726241 · updated
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eastern Cooperative Oncology Group
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT06724237 · updated
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT04269902 · updated
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 2
- Ages 1 to 30
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Legacy Emanuel Children's Hospital · Oregon Health and Science University
- Registry record
- NCT04546399 · updated
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT04840602 · updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Phase 3
- Ages 5 to 60
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Legacy Emanuel Children's Hospital · Oregon Health and Science University · Providence Portland Medical Center
- Registry record
- NCT05675410 · updated
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT06649812 · updated
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Phase 3
- Ages 18 to 39
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT03150693 · updated
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Phase 3
- Ages 60 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05976763 · updated
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT07215910 · updated
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- Phase 3
- Ages 65 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study sites
- Kaiser Permanente Northwest · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT07321652 · updated
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05890352 · updated
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT05633615 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Portland, OR on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Portland
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- Oregon Health and Science University · Providence Portland Medical Center · Providence Saint Vincent Medical Center
- Registry record
- NCT04858334 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Portland, OR on ClinicalTrials.gov.
Ask about studies near Portland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.
Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections